Fenofibrate for Hypertriglyceridemia
Micronized fenofibrate (Tricor - Abbott), a fibric acid derivative structurally similar to clofibrate (Atromid-S, and others) and gemfibrozil (Lopid, and others), has been approved by the FDA for treatment of hypertriglyceridemia. Increased serum triglyceride concentrations have been associated with an increased risk of coronary heart disease (J Jeppesen et al, Circulation, 97:1029, 1998)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Fenofibrate for Hypertriglyceridemia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1030
Article Code: 1030b
Date: July 3, 1998
Volume: 40
Pages: 68-69
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1030
Article Code: 1030b
Date: July 3, 1998
Volume: 40
Pages: 68-69
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)